Business Context and Reporting Period
Company: OKYO Pharma Ltd
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: July 21, 2026
Context: The filing discloses a significant increase in share ownership by the Company's Chairman, Mr. Gabriele Cerrone, through an affiliated entity.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a corporate governance and ownership event rather than financial performance.
Material Changes
- Share Purchase: Mr. Gabriele Cerrone, via Panetta Partners Ltd, purchased 25,000 ordinary shares.
- Transaction Price: $1.40 per share.
- Updated Ownership: Total holdings increased to 10,851,416 ordinary shares.
- Ownership Percentage: The Chairman now holds 20.51% of the issued share capital.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document serves solely to report the share transaction and incorporates the news announcement as Exhibit 99.1.
Investor Verification Checklist
- Verify the beneficial interest structure of Panetta Partners Ltd and its relationship to Mr. Cerrone.
- Confirm the total issued share capital to validate the 20.51% ownership calculation.
- Review the full text of Exhibit 99.1 for any additional context regarding the Chairman's investment rationale.
- Check for any subsequent filings regarding further insider trading activity.